News from us and our partners

Tags

Topics

0 results

News
14 May, 2020
Abivax Receives ANSM and Ethics Committee Clearance to Test its Development Candidate ABX464 in 1,034 COVID-19 Patients in Randomized Phase 2B/3 Clinical Trial
News
14 May, 2020
ABX464 Inhibits Replication of SARS-CoV-2 (COVID-19) in Reconstituted Human Respiratory Epithelium Model
News
13 May, 2020
Genespire and SR-Tiget form gene therapy alliance
News
11 May, 2020
CorVent Medical, A Coridea Portfolio Company, Closes $4.5M Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator
News
6 May, 2020
PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors
News
6 May, 2020
Biotalys’ first biocontrol proves consistent, high efficacy in global fruit and vegetables field trial program
News
4 May, 2020
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
News
30 April, 2020
Pyrowave closes Series B led by Michelin and Sofinnova Partners
News
29 April, 2020
Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies
News
22 April, 2020
EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners
News
22 April, 2020
Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases
News
20 April, 2020
Sofinnova Partners Announces Third Investment from its Italian Fund
News
20 April, 2020
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology
News
20 April, 2020
Biotalys establishes Scientific Advisory Board
News
16 April, 2020
RefleXion Raises $100 Million for Cancer Treatment Commercialization
News
15 April, 2020
GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA

Abivax Receives ANSM and Ethics Committee Clearance to Test its Development Candidate ABX464 in 1,034 COVID-19 Patients in Randomized Phase 2B/3 Clinical Trial

ABX464 Inhibits Replication of SARS-CoV-2 (COVID-19) in Reconstituted Human Respiratory Epithelium Model

Genespire and SR-Tiget form gene therapy alliance

CorVent Medical, A Coridea Portfolio Company, Closes $4.5M Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors

Biotalys’ first biocontrol proves consistent, high efficacy in global fruit and vegetables field trial program

Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference

Pyrowave closes Series B led by Michelin and Sofinnova Partners

Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies

EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners

Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases

Sofinnova Partners Announces Third Investment from its Italian Fund

Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology

Biotalys establishes Scientific Advisory Board

RefleXion Raises $100 Million for Cancer Treatment Commercialization

GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA